Regulus Therapeutics
RGLS
#8386
Rank
โ‚ฌ95.7 M
Marketcap
1,46ย โ‚ฌ
Share price
1.25%
Change (1 day)
-4.77%
Change (1 year)

Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Volume in USD (price x number of shares), data since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚ฌ5.62 M3602.44%
2023โ‚ฌ0.15 M-85.22%
2022โ‚ฌ1.02 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
โ‚ฌ22.53 Mโ‚ฌ43.31 M๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ3.41 Mโ‚ฌ70.14 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ5.11 Mโ‚ฌ63.51 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.08 Mโ‚ฌ0.14 B๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ10.66 Mโ‚ฌ50.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.86 Mโ‚ฌ2.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.47 Mโ‚ฌ0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA